Presentation to highlight advances in fibrostenotic Crohn’s Disease and the potential of localized PDE4 inhibition Carlsbad, CA, Nov. 14, 2024 (GLOBE…
Main Takeaways: Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is financed and…
Company announced completed Phase 1 enrollment for SAB-142 with no observation of serum sickness. The company remains on track for…
Tevogen Bio is a fully functional biotech, with investor-valued assets over $10 billion achieved with under $40 million in spending.Approximately…
November 03, 2024 16:00 ET | Source: Belite Bio, Inc SAN DIEGO, Nov. 03, 2024 (GLOBE NEWSWIRE) -- Belite Bio,…